Necessary role for ventral tegmental area adenylate cyclase and protein kinase A in induction of behavioral sensitization to intraventral tegmental area amphetamine

Journal of Pharmacology and Experimental Therapeutics

Volumn 289, Issue 1, 1999, Pages 38-47

  Tolliver, Bryan K ^a   Ho, Lauren B ^a   Fox, Lisa M ^a   Berger, S Paul ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

9 (TETRAHYDRO 2 FURYL)ADENINE; ADENYLATE CYCLASE; AMPHETAMINE DERIVATIVE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; ENZYME INHIBITION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; VENTRAL TEGMENTUM;

ADENYLATE CYCLASE; AMPHETAMINE; ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; MALE; MICROINJECTIONS; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SUBSTANCE WITHDRAWAL SYNDROME; VENTRAL TEGMENTAL AREA;

EID: 0032892426     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. Beitner-Johnson D and Nestler EJ (1991) Morphine and cocaine exert common chronic actions on tyrosine hydroxylase in dopaminergic brain reward regions. J Neurochem 57:344-347.
2. Beitner-Johnson D, Guitart X and Nestler EJ (1992) Neurofilament proteins and the mesolimbic dopamine system: Common regulation by chronic morphine and chronic cocaine in the rat ventral tegmental area. J Neurosci 12:2165-2176.
3. Beninger RJ (1983) The role of dopamine in locomotor activity and learning. Brain Res Rev 6:173-196.
4. Bijou Y, Stinus L, Le Moal M and Cador M (1996) Evidence for selective involvement of dopamine D1 receptors of the ventral tegmental area in the behavioral sensitization induced by intra-ventral tegmental area injections of D-amphetamine. J Pharmacol Exp Ther 277:1177-1187.
5. Bonci A and Williams JT (1996) A common mechanism mediates long-term changes in synaptic transmission after chronic cocaine and morphine. Neuron 16:631-639.
6. Byrnes JJ, Weinstein DM and Wallace LJ (1997) Robust sensitization to amphetamine after intra-VTA cholera toxin administration. Synapse 25:335-344.
7. Cador M, Bijou Y and Stinus L (1995) Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine. Neuroscience 65:385-395.
8. Cameron DL and Williams JT (1993) Dopamine D1 receptors facilitate transmitter release. Nature 366:344-347.
9. Carboni E, Imperato A, Perezzani L and Di Chiara G (1989) Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neurozcience 28: 653-661.
10. Costall B and Naylor RJ (1977) Mesolimbic and extrapyramidal sites for the mediation of stereotyped behavior patterns and hyperactivity by amphetamine and apomorpbine in the rat, in Cocaine and Other Stimulants (Ellinwood EH and Kilbey MM eds) pp 47-76, Plenum Press, New York.
11. Cunningham ST and Kelley AE (1993) Hyperactivity and sensitization to psychostimulants after cholera toxin infusion into the nucleus accumbens. J Neurosci 13:2342-2350.
12. Dougherty GG and Ellinwood EH (1981) Chronic d-amphetamine in nucleus accumbens: Lack of tolerance or reverse tolerance of locomotor activity. Life Sci 28:2295-2298.
13. Elazar Z and Fuchs S (1991) Phosphorylation by cyclic AMP-dependent protein kinase modulates agonist binding to the D2 dopamine receptor. J Neurochem 56:75-80.
14. Hidaka H, Inayaki M, Kawamoto S and Sasaki Y (1984) Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 23:5036-5041.
15. Hitzmann R, Wu J, Horn D and Loh H (1980) Brain locations controlling the behavioral effects of chronic amphetamine intoxication. Psychopharmacology 72: 93-101.
16. Horger BA, Giles MK and Schenk S (1992) Preexposure to amphetamine and nicotine predisposes rats to self-administer a low dose of cocaine. Psychopharmacology 107:271-276.
17. Horger BA, Shelton K and Schenk S (1990) Preexposure sensitizes rats to the rewarding effects of cocaine. Pharmacol Biochem Behav 37:707-711.
18. Hunter T and Karin M (1992) The regulation of transcription by phosphorylation. Cell 70:375-387.
19. Joh TH, Park DH and Reis DJ (1978) Direct phosphorylation of brain tyrosine hydroxylase by cyclic AMP-dependent protein kinase: Mechanism of enzyme activation. Prof Natl Acad Sci USA 75:4744-4748.
20. Kalivas PW (1993) Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res Rev 18:75-113.
21. Kalivas PW (1995) Interactions between dopamine and excitatory amino acids in behavioral sensitization to psychostimulants. Drug Alcohol Depend 37:95-100.
22. Kalivas PW and Alesdatter JE (1993) Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine. J Pharmacol Exp Ther 267:486-495.
23. Kalivas PW and Duffy P (1995) D1 receptors modulate glutamate transmission in the ventral tegmental area. J Neurosci 15:5379-5388.
24. Kalivas PW and Stewart J (1991) Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Rev 16:223-244.
25. Kalivas PW and Weber B (1988) Amphetamine injection into the ventral mesencephalon sensitizes rats to peripheral amphetamine and cocaine. J Pharmacol Exp Ther 245:1095-1102.
26. Kamata K and Rebec GV (1984) Long-term amphetamine treatment attenuates or reverses the depression of neuronal activity produced by dopamine agonists in the ventral tegmental area. Life Sci 34:2419-2427
27. Kelly PH and Iversen SD (1976) Selective 6-OHDA-induced destruction on mesolimbic dopamine neurons: Abolition of psychostimulant-induced locomotor activity in rats. Eur J Pharmacol 40:45-56.
28. Kim KS, Park DH, Wessel TC, Song B, Wagner J and Joh TH (1993) A dual role for the cAMP-dependent protein kinase on tyrosine hydroxylase gene expression. Proc Natl Acad Sci USA 90:3471-3475.
29. 2 receptors in rat substantia nigra neurones. J Physiol (Lond) 401:437-453.
30. Mansour A, Meador-Woodruff JH, Zhou Q, Civelli O, Akil H and Watson SJ (1992) A comparison of D1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques. Neuroscience 46:959-971.
31. McMillen BA (1983) CNS stimulants: Two distinct mechanisms of action for amphetamine-like drugs. Trends Pharmacol Sci 5:387-390.
32. Miller RJ and Kelly PH (1975) Dopamine-like effects of cholera toxin in the central nervous system. Nature (London) 255:163-166.
33. Miserendino MJD and Nestler EJ (1995) Behavioral sensitization to cocaine: modulation by the cyclic AMP system in the nucleus accumbens. Brain Res 674:299-306.
34. Nestler EJ and Aghajanian GK (1997) Molecular and cellular basis of addiction. Science(Wash DC) 278:58-63.
35. Nestler EJ and Greengard P (1994) Protein phosphorylation and the regulation neuronal function, in Basic Neurochemistry: Molecular, Cellular, and Medical Aspects, 5th ed (Siegel GJ, Agranoff BW, Albers RW, and Molinoff PB eds) pp 449-474, Raven Press, New York.
36. Nestler EJ, Hope BT and Widnell KL (1993) Drug addiction: A model for the molecular basis of neural plasticity. Neuron 11:995-1006.
37. 0-α in discrete regions of rat brain. J Neurochem 55:1079-1082.
38. Nomikos GG, Damsma G, Wenkstern D and Fibiger HC (1990) In vivo characterization of locally applied dopamine uptake inhibitors by striatal microdialysis. Synapse 6:106-112.
39. Oades RD and Halliday GM (1987) Ventral tegmental (A10) system: Neurobiology. 1. Anatomy and connectivity. Brain Res 434:117-165.
40. Paxinos G and Watson C (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
41. Pedarzani P and Storm JF (1995) Protein kinase A-independent modulation of ion channels in the brain by cyclic AMP. Proc Natl Acad Sci USA 92:11716-11720.
42. Perugini M and Vezina P (1994) Amphetamine administered to the ventral tegmental area sensitizes rats to the locomotor effects of nucleus accumbens amphetamine. J Pharmacol Exp Ther 270:690-696.
43. Piazza PV, Deminiere J-M, Le Moal M and Simon H (1989) Factors that predict individual vulnerability to amphetamine self-administration. Science (Wash DC) 246:1511-1513.
44. Piazza PV, Deminiere J-M, Le Moal M and Simon H (1990) Stress- and pharmacologically-induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration. Brain Res 514:22-26.
45. Pierce RC, Born B, Adams M and Kalivas PW (1996) Repeated intra-ventral tegmental area administration of SKF-38393 induces behavioral and neurochemical sensitization to a subsequent cocaine challenge. J Pharmacol Exp Ther 278:384-392.
46. Pierce RC and Kalivas PW (1997) A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Rev 25:192-216.
47. Raymond LA, Blackstone CD and Huganir RL (1993) Phosphorylation and modulation of recombinant GluR6 glutamate receptors by cAMP-dependent protein kinase. Nature (London) 361:637-641.
48. Roberts DCS, Zis AP and Fibiger HC (1975) Ascending catecholaminergic pathways and amphetamine-induced locomotor activity: Importance of dopamine and apparent noninvolvement of norepinephrine. Brain Res 93:441-451.
49. Robinson T and Becker J (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis. Brain Res Rev 11:157-198.
50. Robinson TE and Berridge KC (1993) The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Res Rev 18:247-291.
51. Rosenberg PA, Knowles R, Knowles KP and Li YJ (1994) β-Adrenergic receptor-mediated regulation of extracellular adenosine in cerebral cortex in culture. J Neurosci 14:2953-2965.
52. Saitoh M, Ishikawa T, Matsushima S, Naka M and Hidaka H (1987) Selective inhibition of catalytic activity of smooth muscle light chain kinase. J Biol Chem 262:7796-7801.
53. Shi W-X and Bunney BS (1992) Roles of intracellular cAMP and protein kinase A in the actions of dopamine and neurotensin on midbrain dopamine neurons. J Neurosci 12:2433-2438.
54. Sorg BA and Ulibarri C (1995) Application of a protein synthesis inhibitor into the ventral tegmental area, but not the nucleus accumbens, prevents behavioral sensitization to cocaine. Synapse 20:217-224.
55. Steketee JD (1994) Intra-A10 injection of H7 blocks the development of sensitization to cocaine. Neuroreport 6:69-72.
56. Steketee JD and Kalivas PW (1991) Sensitization to psychostimulants and stress after injection of pertussis toxin into the A10 dopamine region. J Pharmacol Exp Ther 259:916-924.
57. Steketee JD and Kalivas PW (1992) Microinjection of the D2 agonist quinpirole into the A10 dopamine region blocks amphetamine-, but not cocaine-stimulated motor activity. J Pharmacol Exp Ther 261:811-818.
58. Stewart J and Vezina P (1989) Microinjections of SCH-23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systemic amphetamine. Brain Res 495:401-406.
59. Striplin CD and Kalivas PW (1992) Correlation between behavioral sensitization to cocaine and G protein ADP-ribosylation in the ventral tegmental area. Brain Res 579:181-186.
60. Terwilliger R, Beitner-Johnson D, Sevarino KA, Crain SM and Nestler EJ (1991) A general role for adaptations in G proteins and cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res 548:100-110
61. Tolhver BK, Ho LB, Reid MS and Berger SP (1996) Evidence for involvement of ventral tegmental area cyclic AMP systems in behavioral sensitization to psychostimulants. J Pharmacol Exp Ther 278:411-420.
62. 1 dopamine receptor activation is necessary for the induction of sensitization by amphetamine in the ventral tegmental area. J Neurosci 16:2411-2420.
63. Vezina P and Stewart J (1990) Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine: Lack of conditioned effects. Brain Res 516:99-106.
64. Walaas SI and Greengard P (1991) Protein phosphorylation and neuronal function. Pharmacol Rev 43:299-349.
65. Wang L-Y, Salter MW and MacDonald JF (1991) Regulation of kainate receptors by cAMP-dependent protein kinase and phosphatases. Science (Wash DC) 253:1132-1135.
66. White FJ and Wang RY (1984a) Electrophysiological evidence for A10 dopamine autoreceptor subsensitivity after chronic D-amphetamine treatment. Brain Res 309:283-292.
67. White FJ and Wang RY (1984b) A10 dopamine neurons: Role of autoreceptors in determining firing rate and sensitivity to dopamine agonists. Life Sci 34:1161-1170.
68. White FJ, Hu X-T, Zhang X-F and Wolf ME (1995) Repeated administration of cocaine or amphetamine alters neuronal responses to glutamate in the mesoaccumbens dopamine system. J Pharmacol Exp Ther 273:445-454.
69. Wolf ME, Dahlin SL, Hu X-T and Xue C-J (1995) Effects of lesions of prefrontal cortex, amygdala, or fornix on behavioral sensitization to amphetamine: Comparison with N-methyl-D-aspartate antagonists. Neuroscience 69:417-439.
70. Wolf ME, White FJ, Nassar R, Brooderson RJ and Khansa MR (1993) Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. J Pharmacol Exp Ther 264:249-255.
71. Wu Y, Mercuri NB and Johnson SW (1995) Presynaptic inhibition of γ-aminobutyric acid B-mediated synaptic current by adenosine recorded in vitro in midbrain dopamine neurons. J Pharmacol Exp Ther 273:576-581.
72. Zhang X-F, Hu X-T, White FJ and Wolf ME (1997) Increased responsiveness of ventral tegmental area dopamine neurons to glutamate after repeated administration of cocaine or amphetamine is transient and selectively involves AMPA receptors. J Pharmacol Exp Ther 281:699-706.